Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2003
12/25/2003US20030236198 For treatment of infections by drug resistant bacteria
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106454A1 1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
12/24/2003WO2003106452A2 Antagonists of melanin concentrating hormone receptor
12/24/2003WO2003106451A1 Substituted diaminopyrimidines
12/24/2003WO2003106448A2 Novel herbicides
12/24/2003WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2003106413A2 Process for the preparation of oxazolidinones and method of use thereof
12/24/2003WO2003105855A1 Mitotic kinesin inhibitors
12/24/2003WO2003105847A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105781A2 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003093247A3 Antibacterial agents
12/24/2003WO2003091675A3 Ultrasonic doppler effect speed measurement
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CA2489458A1 Substituted diaminopyrimidines
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2488802A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667401 Method for producing heterocyclic compounds
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/23/2003US6667328 Such as 2-(N-Cyanoimino)-5-((E)-4-styrylbenzylidene)thiazol-idin-4-one; prophylaxis of hypolipidemic/hypoglycemic, hyper-/hypo-cholesterolemia activity
12/23/2003US6667326 Thienyl, thiazolyl, isothiazolyl or thiadiazoyl derivatives
12/23/2003US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV)
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667310 Insecticides
12/23/2003US6667303 Aryl substituted 1,4-diazepanes and method of use thereof
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/18/2003WO2003104257A2 Protease inhibitors
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104224A1 Metabolites of prinomastat and their sythesis
12/18/2003WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003103712A1 Combinations comprising epothilones and pharmaceutical uses thereof
12/18/2003WO2003103686A1 Thrombopoietin mimetics
12/18/2003WO2003103677A1 Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003WO2003074504A3 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003064431A3 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
12/18/2003WO2003039440A3 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003024401A3 Piperizinones as modulators of chemokine receptor activity
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003US20030232990 For therapy of arteriosclerosis and dyslipidaemias
12/18/2003US20030232869 N3 alkylated benzimidazole derivatives as MEK inhibitors
12/18/2003US20030232866 Such as 2-bromo-6-methoxy-5-(5-oxazolyl)-1H-indole-3-carboxaldehyde for treating disorders associated with inosine monophosphate dehydrogenase (IMPDH); immunosuppressants, anti-cancer agents
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232860 Medicine comprising dicyanopyridine derivative
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232843 (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232842 Nitrogen compounds such as methyl 4-(2-chloro-4-fluorophenyl) -2-(3,5-difluoropyridin-2-yl)-6-(4-morpholinylmethyl)-1,4-dihydropyrimidine -5-carboxylate, with mixtures of lamivudine and interferons, used as viricides; hepatitis
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232833 Benzofuran derivatives
12/18/2003US20030232825 Benzoxazine derivatives and uses thereof
12/18/2003US20030232821 Oxadiazine derivatives
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232812 Microbiocides used to treat eye and skin infections
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030229950 Hair dyes
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488193A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003CA2487147A1 Combinations comprising epothilones and pharmaceutical uses thereof
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1371648A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370550A1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370543A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370261A2 New use
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003EP0828738B1 Pyridyl-thiazoles and their use to protect plants against infections by micro-organisms
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 628